{"ticker":"HALO","companyName":"HALOZYME THERAPEUTICS, INC.","fiscalYear":2025,"executiveName":"Helen I. Torley","executiveTitle":"President and Chief Executive Officer","totalComp":23166223,"salary":1000000,"stockAwards":19350145,"optionAwards":1650014,"nonEquityIncentive":1147500,"otherComp":18564,"yoyChangePct":81.8182053634363,"source":{"filingType":"DEF 14A","filingDate":"2026-03-23","filingUrl":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm"},"lastUpdated":"2026-04-04T07:59:49.234Z"}